• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

No difference in outcomes between 3 minimally invasive surgical procedures for treatment of lumbar spinal stenosis

byZoya GomesandMichael Pratte
April 6, 2022
in Chronic Disease, Orthopedic Surgery, Surgery
Reading Time: 3 mins read
No difference in outcomes between 3 minimally invasive surgical procedures for treatment of lumbar spinal stenosis
Share on FacebookShare on TwitterShare on LinkedIn

1. In this randomized clinical trial of 437 patients, no significant difference was observed in clinical outcomes between 3 minimally invasive posterior decompression techniques for the treatment of lumbar spinal stenosis over a 2-year period.

2. After adjusting for baseline Oswestry Disability Index (ODI) and operating hospital, there was no statistically significant difference in the change in disability measured with ODI between any of the 3 surgical techniques.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Lumbar spinal stenosis (LSS) is a common condition that is characterized by pain and discomfort in the lower back and extremities. Treatment for LSS can include both surgical and nonsurgical interventions. In surgical treatment, there are various options for minimally invasive posterior decompression of the adult lumbar spine, 3 of which are unilateral laminotomy with crossover (UL), bilateral laminotomy (BL), and spinous process osteotomy (SPO). The effectiveness of these techniques relative to one another is, however, unknown. This study compared the effectiveness of these 3 minimally invasive posterior decompression techniques for LSS. In total, 437 patients were randomized to undergo 1 of the 3 surgical techniques, with a median age of 68 years. The primary outcome was change in disability measured with Oswestry Disability Index (ODI) from baseline to 24 months after the surgical procedure. Secondary outcomes included mean change in quality of life, disease-specific symptom severity, back and leg pain, patient perceived benefit and duration of the surgical procedure, perioperative bleeding volume, complications, number of reoperations and length of hospital stay. After completing analyses, no statistically significant differences were found regarding the change in disability measured using the ODI between the UL, BL and SPO surgical groups. The BL technique was found to take the least amount of time at approximately 124 minutes, while the UL and SPO procedure took on average 30 minutes more time. A major strength of this study was its randomized clinical trial design and large sample size. A limitation to this study was that the 3 minimally invasive surgical techniques for treatment of LSS were not compared with a full laminectomy.

Click to read the study in JAMA Network Open

Relevant Reading: Surgical versus nonoperative treatment for lumbar spinal stenosis four-year results of the Spine Patient Outcomes Research Trial

RELATED REPORTS

Fusion for spinal stenosis not associated with improved clinical outcomes: the Swedish Spinal Stenosis Study

Similar outcomes between physical therapy and surgery for lumbar spinal stenosis

In-Depth [randomized controlled trial]: This study investigated the effectiveness of 3 minimally invasive poster decompression techniques: unilateral laminotomy with crossover (UL), bilateral laminotomy (BL), and spinous process osteotomy (SPO), for the treatment of lumbar spinal stenosis. A total of 437 patients were enrolled and underwent randomization to received either UL (n=146), BL (n=142) or SPO (n=149), with a median age of 68 years and included 230 men (53%). The primary outcome assessed was change in disability measured using the Oswestry Disability Index (ODI) over 2 years. The mean change in ODI from baseline to 2-year follow-up for the entire cohort was -19.1 (95% CI, -20.8 to -17.5). After adjusting for baseline ODI and the operating hospital, the estimated change in ODI after the 2-year follow-up period for UL, BL and SPO was -17.8 (95% CI, -20.3 to -15.3), -18.7 (95% CI, -21.3 to -16.0), and -21.0 (95% CI, -23.5 to 18.4) respectively. Ultimately, no statistically significant difference was found in the primary outcome between the 3 surgical techniques (P= .214). No statistically significant difference in secondary outcomes were observed between the 3 surgical groups, however the BL group was found to have a longer mean duration of the surgical procedure, 123.9 (109.0 to 138.7) minutes, compared with UL, 95.7 (81.1 to 110.3) minutes and SPO, 92.9 (78.2 to 107.7) minutes, (P<.001).

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: spinal stenosis
Previous Post

Obesity may be associated with better response to immune checkpoint blockade therapy

Next Post

#VisualAbstract: Sirolimus plus prednisolone was superior to sirolimus monotherapy in treating patients with kaposiform hemangioendothelioma

RelatedReports

Chronic Disease

Fusion for spinal stenosis not associated with improved clinical outcomes: the Swedish Spinal Stenosis Study

April 15, 2016
Similar outcomes between physical therapy and surgery for lumbar spinal stenosis
Chronic Disease

Similar outcomes between physical therapy and surgery for lumbar spinal stenosis

April 6, 2015
Celiac disease more prevalent in children with irritable bowel syndrome
Emergency

2 Minute Medicine Rewind June 30 – July 7, 2014

July 7, 2014
No benefit with glucocorticoid injection for spinal stenosis
Chronic Disease

No benefit with glucocorticoid injection for spinal stenosis

July 3, 2014
Next Post
#VisualAbstract: Sirolimus plus prednisolone was superior to sirolimus monotherapy in treating patients with kaposiform hemangioendothelioma

#VisualAbstract: Sirolimus plus prednisolone was superior to sirolimus monotherapy in treating patients with kaposiform hemangioendothelioma

Being overweight and obese associated with increased incidence of chronic kidney disease

2 Minute Medicine Rewind April 4, 2022

Neonatal neuroimaging with strong negative predictive value for developmental outcomes: The NEURO study

Enteric administration of recombinant human insulin to preterm infants is safe and effective

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.